- Home
- ROIV vs DBX Comparison
ROIV vs DBX Comparison
Compare ROIV & DBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- DBX
- Stock Information
- Founded
- ROIV 2014
- DBX 2007
- Country
- ROIV United Kingdom
- DBX United States
- Employees
- ROIV N/A
- DBX N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- DBX Computer Software: Prepackaged Software
- Sector
- ROIV Health Care
- DBX Technology
- Exchange
- ROIV Nasdaq
- DBX Nasdaq
- Market Cap
- ROIV 8.6B
- DBX 8.3B
- IPO Year
- ROIV N/A
- DBX 2018
- Fundamental
- Price
- ROIV $18.82
- DBX $28.32
- Analyst Decision
- ROIV Strong Buy
- DBX Hold
- Analyst Count
- ROIV 8
- DBX 6
- Target Price
- ROIV $21.06
- DBX $29.80
- AVG Volume (30 Days)
- ROIV 7.6M
- DBX 2.6M
- Earning Date
- ROIV 11-10-2025
- DBX 11-06-2025
- Dividend Yield
- ROIV N/A
- DBX N/A
- EPS Growth
- ROIV N/A
- DBX N/A
- EPS
- ROIV N/A
- DBX 1.57
- Revenue
- ROIV $23,233,000.00
- DBX $2,532,800,000.00
- Revenue This Year
- ROIV N/A
- DBX N/A
- Revenue Next Year
- ROIV $320.50
- DBX N/A
- P/E Ratio
- ROIV N/A
- DBX $18.11
- Revenue Growth
- ROIV N/A
- DBX N/A
- 52 Week Low
- ROIV $8.73
- DBX $24.42
- 52 Week High
- ROIV $18.96
- DBX $33.33
- Technical
- Relative Strength Index (RSI)
- ROIV 81.18
- DBX 41.67
- Support Level
- ROIV $17.89
- DBX $29.17
- Resistance Level
- ROIV $18.96
- DBX $29.72
- Average True Range (ATR)
- ROIV 0.50
- DBX 0.63
- MACD
- ROIV 0.06
- DBX -0.07
- Stochastic Oscillator
- ROIV 95.45
- DBX 26.91
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About DBX Dropbox Inc.
Dropbox provides cloud storage and content collaboration tools, focusing on individuals and small to midsize businesses. Founded in 2007, Dropbox was a pioneer in the file sync and share market. In recent years, the firm has been emphasizing its Dash product, which facilitates AI-powered universal search across unstructured cloud data.